Achieve Life Sciences (ACHV) Share-based Compensation (2010 - 2026)

Achieve Life Sciences (ACHV) has 17 years of Share-based Compensation data on file, last reported at $9.1 million in Q1 2026.

• Quarterly Share-based Compensation rose 307.71% year-over-year to $9.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.1 million (up 760.11% YoY) and the FY2025 annual result came in at $2.9 million, up 20.83% from the prior year.
• Share-based Compensation improved to $9.1 million in Q1 2026, from -$7.5 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $9.1 million in Q1 2026 to a low of -$7.5 million in Q4 2025.
• A 5-year average of $1.2 million and a median of $1.3 million in 2024 frame the typical range for Share-based Compensation.
• Annual changes were most pronounced in 2022 — Share-based Compensation soared 547.77% — and 2024, when it slumped 216.71%.
• Tracing ACHV's Share-based Compensation over 5 years: stood at $3.2 million in 2022, then advanced by 6.25% to $3.4 million in 2023, then tumbled by 216.71% to -$4.0 million in 2024, then sank by 88.0% to -$7.5 million in 2025, then jumped by 221.98% to $9.1 million in 2026.
• The last three Share-based Compensation figures came in at $9.1 million (Q1 2026), -$7.5 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.